BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17092559)

  • 1. Could ATRA/Idarubicin treatment of acute promyelocytic leukemia induce the appearance of new clonal cytogenetic abnormalities in patients in complete remission?
    Mallo M; Salido M; Espinet B; Cervera J; Canellas A; Pajuelo JC; Pedro C; Florensa L; Sanz MA; Solé F
    Leuk Res; 2007 Sep; 31(9):1315-7. PubMed ID: 17092559
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid response to induction in a case of acute promyelocytic leukemia with MYC amplification on double minutes at diagnosis.
    Zuberi L; Adeyinka A; Kuriakose P
    Cancer Genet Cytogenet; 2010 Apr; 198(2):170-2. PubMed ID: 20362234
    [No Abstract]   [Full Text] [Related]  

  • 3. Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMA.
    Hernández JM; Martín G; Gutiérrez NC; Cervera J; Ferro MT; Calasanz MJ; Martínez-Climent JA; Luño E; Tormo M; Rayón C; Díaz-Mediavilla J; González M; González-San Miguel JD; Pérez-Equiza K; Rivas C; Esteve J; Alvarez Mdel C; Odriozola J; Ribera JM; Sanz MA;
    Haematologica; 2001 Aug; 86(8):807-13. PubMed ID: 11522536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemia.
    Dalal BI; Bruyere H; Barnett MJ
    Br J Haematol; 2007 Jun; 137(5):385. PubMed ID: 17374141
    [No Abstract]   [Full Text] [Related]  

  • 5. Translocation (2;11)(q37;q23) in therapy-related myelodysplastic syndrome after treatment for acute promyelocytic leukemia.
    Snijder S; Mellink CH; van der Lelie H
    Cancer Genet Cytogenet; 2008 Jan; 180(2):149-52. PubMed ID: 18206542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and prognosis analysis of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide as the front-line therapy.
    Lou Y; Suo S; Tong H; Ye X; Wang Y; Chen Z; Qian W; Meng H; Mai W; Huang J; Tong Y; Jin J
    Leuk Res; 2013 Nov; 37(11):1451-6. PubMed ID: 23958062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy.
    Breccia M; Diverio D; Noguera NI; Visani G; Santoro A; Locatelli F; Damiani D; Marmont F; Vignetti M; Petti MC; Lo Coco F
    Haematologica; 2004 Jan; 89(1):29-33. PubMed ID: 14754603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group.
    Ortega JJ; Madero L; Martín G; Verdeguer A; García P; Parody R; Fuster J; Molines A; Novo A; Debén G; Rodríguez A; Conde E; de la Serna J; Allegue MJ; Capote FJ; González JD; Bolufer P; González M; Sanz MA;
    J Clin Oncol; 2005 Oct; 23(30):7632-40. PubMed ID: 16234524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of additional chromosome abnormalities on the outcome of newly diagnosed acute promyelocytic leukemia treated with red arsenic sulfide and all trans-retinoic acid plus anthracyclin based protocol].
    Lu J; Jiang H; Jiang Q; Bao L; Lu XJ; Zhang Y; Lin W; Liu YR; Huang XJ; Jiang B
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2254-7. PubMed ID: 19087672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late relapse of acute promyelocytic leukemia treated with all- trans retinoic acid and chemotherapy: report of two cases.
    Ferrara F; Selleri C; Mele G; Serio B; Palmieri S; Pocali B; Pane F; Rotoli B
    Ann Hematol; 2004 Jul; 83(7):484-6. PubMed ID: 14730393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy.
    Serefhanoglu S; Buyukasik Y; Goker H; Sayinalp N; Haznedaroglu IC; Aksu S; Ozcebe OI; Turgut M; Aslan R; Ozdemir E
    Leuk Res; 2010 Dec; 34(12):e317-9. PubMed ID: 20696473
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of ATRA-induced isolated myocarditis in the absence of circulating malignant cells: demonstration of the t(15;17) translocation in the inflammatory infiltrate by in situ hybridisation.
    van Rijssel RH; Wegman J; Oud ME; Pals ST; van Oers MH
    Leuk Res; 2010 Jul; 34(7):e142-4. PubMed ID: 20060166
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL).
    Gupta V; Yi QL; Brandwein J; Lipton JH; Messner HA; Schuh AC; Wells RA; Minden MD
    Leuk Res; 2005 Jan; 29(1):113-4. PubMed ID: 15541484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients.
    Dai CW; Zhang GS; Shen JK; Zheng WL; Pei MF; Xu YX; Cao YX; Yi Y; Yang JJ; Peng HL; Zhong HY; Li RJ
    Acta Haematol; 2009; 121(1):1-8. PubMed ID: 19246888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel clonal t(1;4)(p36.1;q31) translocation in acute promyelocytic leukaemia.
    Zhang X; Pan J
    J Clin Pathol; 2015 May; 68(5):391-3. PubMed ID: 25759405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current situation and perspective for treatment of acute myelogenous leukemia in adults].
    Fukushima T; Ueda T
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):295-302. PubMed ID: 9492819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idarubicin in acute leukemias: experience of the Italian Cooperative Group GIMEMA.
    Petti MC; Mandelli F
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):10-5. PubMed ID: 2928805
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute pancreatitis during all-trans-retinoic acid treatment for acute promyelocytic leukemia in a patient without overt hypertriglyceridemia.
    Teng HW; Bai LY; Chao TC; Wang WS; Chen PM
    Jpn J Clin Oncol; 2005 Feb; 35(2):94-6. PubMed ID: 15709095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation.
    Breccia M; Cimino G; Alimena G; De Carolis S; Lo Coco F; Mandelli F
    Haematologica; 2002 Feb; 87(2):ELT12. PubMed ID: 11836189
    [No Abstract]   [Full Text] [Related]  

  • 20. Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
    Cervera J; Montesinos P; Hernández-Rivas JM; Calasanz MJ; Aventín A; Ferro MT; Luño E; Sánchez J; Vellenga E; Rayón C; Milone G; de la Serna J; Rivas C; González JD; Tormo M; Amutio E; González M; Brunet S; Lowenberg B; Sanz MA
    Haematologica; 2010 Mar; 95(3):424-31. PubMed ID: 19903674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.